NeurAxis, Inc. (NRXS)
6.21
+0.10
(+1.64%)
USD |
NYAM |
Nov 06, 10:14
NeurAxis Shareholders Equity (Quarterly) : 6.735M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 6.735M |
| March 31, 2026 | 5.748M |
| December 31, 2025 | 3.399M |
| September 30, 2025 | 2.285M |
| June 30, 2025 | 4.253M |
| March 31, 2025 | 0.2585M |
| December 31, 2024 | 2.068M |
| September 30, 2024 | -1.794M |
| June 30, 2024 | -5.258M |
| March 31, 2024 | -3.184M |
| Date | Value |
|---|---|
| December 31, 2023 | -1.403M |
| September 30, 2023 | -1.061M |
| June 30, 2023 | -9.983M |
| March 31, 2023 | -7.747M |
| December 31, 2022 | -5.574M |
| September 30, 2022 | |
| June 30, 2022 | |
| March 31, 2022 | |
| December 31, 2021 | -0.8257M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Abbott Laboratories | 51.03B |
| AngioDynamics, Inc. | 163.96M |
| Alphatec Holdings, Inc. | 21.30M |
| AtriCure, Inc. | 533.22M |
| Baxter International, Inc. | 6.502B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 9.996M |
| Total Liabilities (Quarterly) | 3.261M |
| Debt to Equity Ratio | 0.0415 |
| Current Ratio | 3.040 |
| Net Debt Paydown Yield | 0.02% |